154 related articles for article (PubMed ID: 8329833)
41. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.
Oostdijk W; Hümmelink R; Odink RJ; Partsch CJ; Drop SL; Lorenzen F; Sippell WG; van der Velde EA; Schultheiss H
Eur J Pediatr; 1990 Feb; 149(5):308-13. PubMed ID: 2138079
[TBL] [Abstract][Full Text] [Related]
42. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
Lin TH; LePage ME; Henzl M; Kirkland JL
J Pediatr; 1986 Dec; 109(6):954-8. PubMed ID: 2946840
[TBL] [Abstract][Full Text] [Related]
43. Preserving adult height potential in girls with idiopathic true precocious puberty.
Kreiter M; Burstein S; Rosenfield RL; Moll GW; Cara JF; Yousefzadeh DK; Cuttler L; Levitsky LL
J Pediatr; 1990 Sep; 117(3):364-70. PubMed ID: 2144020
[TBL] [Abstract][Full Text] [Related]
44. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
45. [True precocious puberty in girl. Therapy with LHRH analogs].
Wasikowa R; Iwanicka Z; Pellar J; Hirowska I; Barg E
Kinderarztl Prax; 1990 Jul; 58(7):335-40. PubMed ID: 2145459
[TBL] [Abstract][Full Text] [Related]
46. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
Brito VN; Latronico AC; Cukier P; Teles MG; Silveira LF; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2008 Jul; 93(7):2662-9. PubMed ID: 18460564
[TBL] [Abstract][Full Text] [Related]
47. [Growth and precocious puberty. Results of treatment by LHRH analogs].
Chaussain JL; Hamdani K; Swaenepoel C
Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():285-6. PubMed ID: 1449381
[No Abstract] [Full Text] [Related]
48. Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment.
Couto-Silva AC; Adan L; Trivin C; Brauner R
J Pediatr Endocrinol Metab; 2002 Mar; 15(3):297-305. PubMed ID: 11924932
[TBL] [Abstract][Full Text] [Related]
49. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
Chen SK; Fan X; Tang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
[TBL] [Abstract][Full Text] [Related]
50. Idiopathic precocious puberty versus puberty in adopted children; auxological response to gonadotrophin-releasing hormone agonist treatment and final height.
Kempers MJ; Otten BJ
Eur J Endocrinol; 2002 Nov; 147(5):609-16. PubMed ID: 12444892
[TBL] [Abstract][Full Text] [Related]
51. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
[TBL] [Abstract][Full Text] [Related]
52. Combined therapy with GnRH analog plus growth hormone in central precocious puberty.
Pucarelli I; Segni M; Ortore M; Moretti A; Iannaccone R; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():811-20. PubMed ID: 10969926
[TBL] [Abstract][Full Text] [Related]
53. The clinical effects of gonadotropin-releasing hormone agonists for the treatment of children patients with central precocious puberty.
Xue Y; Wang P; Wang SQ; Gao YQ
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):5014-5017. PubMed ID: 30070338
[TBL] [Abstract][Full Text] [Related]
54. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue.
Lindner D; Job JC; Chaussain JL
Eur J Pediatr; 1993 May; 152(5):393-6. PubMed ID: 8319702
[TBL] [Abstract][Full Text] [Related]
55. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty.
Swaenepoel C; Chaussain JL; Roger M
Horm Res; 1991; 36(3-4):126-30. PubMed ID: 1840142
[TBL] [Abstract][Full Text] [Related]
56. Triptorelin (Triptodur) for central precocious puberty.
Med Lett Drugs Ther; 2018 Jan; 60(1537):7-8. PubMed ID: 29294465
[No Abstract] [Full Text] [Related]
57. Height prognosis in girls with central precocious puberty treated with GnRH analogues.
Kelnar CJ; Stanhope R
Clin Endocrinol (Oxf); 2002 Mar; 56(3):295-6. PubMed ID: 11940039
[No Abstract] [Full Text] [Related]
58. Near final height after GnRH agonist treatment in central precocious puberty.
Micillo M; Salerno M; Officioso A; Perna E; Gasparini N; Pisaturo L; Di Maio S
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():787-90. PubMed ID: 10969922
[TBL] [Abstract][Full Text] [Related]
59. Local reactions to luteinizing hormone releasing hormone analog therapy.
Tonini G; Marinoni S; Forleo V; Rustico M
J Pediatr; 1995 Jan; 126(1):159-60. PubMed ID: 7815213
[No Abstract] [Full Text] [Related]
60. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty.
Rizzo V; De Sanctis V; Corrias A; Fortini M; Galluzzi F; Bertelloni S; Guarneri MP; Pozzan G; Cisternino M; Pasquino AM
J Pediatr Endocrinol Metab; 2000 Jul; 13 Suppl 1():781-6. PubMed ID: 10969921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
